Donald Yakel, MD
Interventional Cardiology · Springfield, ILNPI 1568559359
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (42.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Abbott at 50.5% of the total. Reporting peaked in 2022 at $17,430 and has fallen 79.1% since, to $3,641 in 2025. Among interventional cardiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 398 payments — averaging $136.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$27K
- Medtronic$13K
- Edwards Lifesciences$3K
- Cordis US CORP.$3K
- Philips North America LLC$2K
- Boston Scientific$2K
- plus $5K from 28 others
Across 43 payments — averaging $10,439 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$346K
- Janssen Research & Development, LLC$103K
What the payments were for
- Consulting fees$9,50017%
- Speaking & faculty fees$7,50014%
- Travel & lodging$23,05442%
- Food & beverage$14,37026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 123 | $27,493 |
| Medtronic(2 entities) | 76 | $12,758 |
| Edwards Lifesciences | 20 | $2,859 |
| Cordis US CORP. | 11 | $2,661 |
| Philips North America LLC | 7 | $2,054 |
| Boston Scientific | 22 | $1,905 |
| Abiomed | 20 | $777 |
| Novartis | 23 | $421 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $412 |
| Cardiovascular Systems Inc. | 9 | $401 |
| W. L. Gore & Associates, Inc. | 13 | $391 |
| Shockwave Medical, Inc | 3 | $248 |
| Penumbra, Inc. | 2 | $248 |
| Teleflex LLC | 8 | $217 |
| GE HealthCare | 2 | $195 |
| ZOLL Circulation Inc | 2 | $180 |
| Asahi Intecc USA, Inc. | 6 | $157 |
| Amgen | 5 | $154 |
| Inari Medical, Inc. | 1 | $149 |
| Novo Nordisk | 1 | $122 |
| Endologix LLC | 1 | $80 |
| Arrow International, Inc. | 1 | $77 |
| Lemaitre Vascular, Inc. | 3 | $65 |
| Johnson & Johnson | 4 | $64 |
| Boehringer Ingelheim | 3 | $58 |
| Terumo Medical Corporation | 2 | $44 |
| Angiodynamics, Inc. | 2 | $44 |
| Pfizer | 2 | $43 |
| Cook Medical LLC | 2 | $38 |
| Livanova USA, Inc. | 1 | $36 |
| Surmodics, Inc. | 1 | $27 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| AstraZeneca | 1 | $14 |
| Cardinal Health 200 LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azure$5,995
- DRAGONFLY OPSTAR$5,376
- XIENCE SIERRA$5,305
- COROFLOW$4,929
- Omnilink Elite vascular stent system$2,842
- ANGIOGUARD$2,552
- Dragonfly OCT$2,500
- IGT D Peripheral$1,898
- OPTIS$1,814
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,736
- COREVALVE EVOLUT R$1,520
- IN.PACT Admiral$1,475
- XACT$798
- ROTABLATOR$688
- GENERAL VASCULAR ACCESS$616
- VenaSeal$601
- PRESSUREWIRE$519
- SAPIEN 3 Ultra RESILIA$417
- Abre$296
- Impella$276
How this compares
$54,425 in reported general payments places this provider in the 90th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 235 | $257,688 |
| EntrestoSacubitril/Valsartan | 35 | $44,547 |
| XareltoRivaroxaban | 35 | $37,684 |
| BrilintaTicagrelor | 38 | $35,319 |
| JardianceEmpagliflozin | 22 | $31,917 |
| ClopidogrelClopidogrel Bisulfate | 588 | $6,555 |
| Metoprolol Succinate | 462 | $4,926 |
| Atorvastatin Calcium | 286 | $2,429 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 182 | $1,770 |
| Isosorbide Dinitrate | 21 | $1,685 |
| Carvedilol | 181 | $1,678 |
| Nitroglycerin | 95 | $1,625 |
| Amiodarone Hcl | 38 | $1,288 |
| Losartan Potassium | 166 | $1,189 |
| Lisinopril | 162 | $1,097 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $43 | $257,688235 claims |
| NovartisEntresto | $421 | $44,54735 claims |
| Johnson & JohnsonXarelto | $64 | $37,68435 claims |
| AstraZenecaBrilinta | $14 | $35,31938 claims |
| Boehringer IngelheimJardiance | $58 | $31,91722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 303 interventional cardiology providers in Illinois.
Other interventional cardiology in Springfield
- Tony de MartiniSpringfield$208K
- Shady HenienSpringfield$105K
- Jack HallSpringfield$40K
- Krishna Rocha SinghSpringfield$25K
- Andrei PopElk Grove Village$900K
- Atman ShahChicago$788K
- Ravi RamanaPalos Park$458K
- Mahesh RajuDowners Grove$281K
- Mark RicciardiEvanston$253K
- Neal SawlaniPark Ridge$246K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.